Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
534 studies found for:    Open Studies | "Melanoma"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Prospective Melanoma Database
Condition: Melanoma
Intervention: Other: clinical biological data collection on melanoma
2 Not yet recruiting LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
Condition: Melanoma
Interventions: Drug: LY3022855;   Drug: Vemurafenib;   Drug: Cobimetinib
3 Recruiting Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Condition: Melanoma
4 Recruiting A Clinical Trial of Patients With Melanoma
Condition: Melanoma
Interventions: Drug: Digoxin Combination;   Drug: Dabrafenib;   Drug: Trametinib
5 Recruiting Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas
Condition: Melanoma
Intervention: Radiation: Protontherapy
6 Recruiting A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Metformin
7 Recruiting A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
Condition: Melanoma
Interventions: Drug: pembrolizumab + epacadostat;   Drug: pembrolizumab + placebo
8 Recruiting In Vivo Real-time Detection of Circulating Melanoma Cells
Condition: Melanoma
9 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
10 Recruiting BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: BGB324+pembrolizumab;   Drug: BGB324+dabrafenib and trametinib;   Drug: pembrolizumab;   Drug: dabrafenib and trametinib
11 Recruiting Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Condition: Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Drug: Metformin
12 Not yet recruiting SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Conditions: Melanoma;   Metastatic Melanoma
Interventions: Radiation: SAbR;   Drug: Ipilimumab;   Drug: Nivolumab
13 Recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
14 Recruiting A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Condition: Melanoma
Interventions: Biological: Poly-ICLC;   Biological: Peptides
15 Not yet recruiting Tracing Dissemination of Melanoma Cells in Healthy Tissues
Condition: Melanoma
Intervention: Procedure: Melanoma and peritumoral skin excision
16 Recruiting Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
Condition: Melanoma
Intervention: Drug: regorafenib
17 Recruiting Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
Condition: Malignant Melanoma
18 Recruiting A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: NKT cells
19 Recruiting PLX3397 KIT in Acral aNd mucOsal Melanoma
Condition: Malignant Melanoma
Intervention: Drug: PLX3397
20 Not yet recruiting Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma
Condition: Metastatic Melanoma
Interventions: Drug: Pembrolizumab;   Drug: Dabrafenib;   Drug: Trametinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.